Rotation to OpTimal Albuminuria Treatment Evaluation: A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetes

Trial Profile

Rotation to OpTimal Albuminuria Treatment Evaluation: A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetes

Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2016

At a glance

  • Drugs Empagliflozin (Primary) ; Linagliptin (Primary) ; Losartan (Primary) ; Sulodexide (Primary)
  • Indications Diabetes mellitus; Proteinuria
  • Focus Therapeutic Use
  • Acronyms ROTATE
  • Most Recent Events

    • 22 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top